Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $46 | $29 | $27 |
| Short-Term Investments | $0 | $2 | $0 | $0 |
| Receivables | $191 | $136 | $116 | $144 |
| Inventory | $315 | $328 | $319 | $330 |
| Other Curr. Assets | $4 | $5 | $3 | -$12 |
| Total Curr. Assets | $559 | $516 | $468 | $490 |
| Property Plant & Equip (Net) | $305 | $294 | $288 | $287 |
| Goodwill | $0 | $3 | $0 | $0 |
| Intangibles | $0 | $33 | $36 | $34 |
| Long-Term Investments | $0 | $19 | $19 | $19 |
| Tax Assets | $4 | $4 | $3 | $2 |
| Other NC Assets | $19 | $0 | $0 | $0 |
| Total NC Assets | $363 | $353 | $346 | $342 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $922 | $870 | $814 | $832 |
| Liabilities | – | – | – | – |
| Payables | $102 | $65 | $91 | $87 |
| Short-Term Debt | $0 | $28 | $23 | $24 |
| Tax Payable | $22 | $7 | $8 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $61 | $87 | $4 | $44 |
| Total Curr. Liab. | $185 | $187 | $126 | $157 |
| LT Debt | $0 | $0 | $0 | $91 |
| Deferred Rev, NC | $6 | $6 | $3 | $3 |
| Deferred Tax Liab, NC | $1 | $1 | $0 | $0 |
| Other NC Liab. | $98 | $102 | $85 | $0 |
| Total NC Liab. | $104 | $108 | $88 | $94 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $16 |
| Total Liabilities | $289 | $295 | $214 | $250 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $535 | $477 | $503 | $486 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $83 | $84 | $83 | $83 |
| Total Equity | $622 | $564 | $590 | $572 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $11 | $11 | $10 | $10 |
| Total Liab. & Tot. Equity | $922 | $870 | $814 | $832 |
| Net Debt | -$49 | -$18 | -$6 | $87 |